A compound in
green tea, EGCG (epigallocatechin gallate), works as well in moderately diabetic mice as
GlaxoSmithKline’s diabetes drug Avandia, according to researchers from Sweden’s Karolinska Institute.
In the study, 5-week-old moderately diabetic and severely diabetic mice were fed EGCG or given Avandia. After five and 10 weeks of treatment, the blood sugar and insulin levels of the mice were tested.
Moderately diabetic mice did just as well on the green tea extract as they did on Avandia. Severely diabetic mice did not benefit as much from EGCG.
Researchers said the EGCG, though less potent than Avandia, “exerted changes that were similarly beneficial.”
These are hefty risks for a drug designed to treat a disease that is virtually 100 percent curable with SIMPLE lifestyle changes (more on these later).
No comments:
Post a Comment